Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
US-9855332-B2 · Jan 2, 2018 · US
This page is not indexed by search engines while we improve data quality.
Kovacevich Brian Robert — Human Necessities
Kovacevich Brian Robert holds 3 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Kovacevich Brian Robert |
| Technology | Human Necessities |
| Patents in slice | 3 |
| Recent patents in slice | 0 |
| First year | 2017 |
| Last year | 2018 |
Representative patents
Notable publications linking Kovacevich Brian Robert to Human Necessities.
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
US-9855332-B2 · Jan 2, 2018 · US
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
US-9855332-B2 · Jan 2, 2018 · US
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
US-9855332-B2 · Jan 2, 2018 · US
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
US-9855332-B2 · Jan 2, 2018 · US
Recent filings
Latest patents from Kovacevich Brian Robert in Human Necessities.
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
US-9855332-B2 · Jan 2, 2018 · US
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
US-9855332-B2 · Jan 2, 2018 · US
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
US-9855332-B2 · Jan 2, 2018 · US
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
US-9855332-B2 · Jan 2, 2018 · US
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
US-9855332-B2 · Jan 2, 2018 · US
Related pages
Navigate to parent entity pages.